ATROVENT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug ATROVENT contains one active pharmaceutical ingredient (API):

1 Ipratropium bromide anhydrous UNII J697UZ2A9J - IPRATROPIUM BROMIDE

Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol). Read about Ipratropium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ATROVENT Nebuliser solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
ATROVENT HFA Inhalation aerosol, metered	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AX03	Ipratropium bromide	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AX Other nasal preparations
Discover more medicines within R01AX03
R03BB01	Ipratropium bromide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1542E, 4089F, 4090G, 8238N, 8671J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 504500501178319, 504500504177313
Country: CA	Health Products and Food Branch	Identifier(s): 02247686
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.076-04-03, 29385-1-09-10
Country: EE	Ravimiamet	Identifier(s): 1057711, 1105940, 1567470, 1874448
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 54674, 61184, 61185, 61848
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 099486, 129817
Country: FR	Base de données publique des médicaments	Identifier(s): 61267669, 65756091, 66698997, 66871253, 67838060, 69720897
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 180714, 201649, 299787, 299788, 299790, 299791, 32225, 32266, 375964, 73900
Country: HK	Department of Health Drug Office	Identifier(s): 23564, 36372, 50402
Country: IE	Health Products Regulatory Authority	Identifier(s): 14397, 67618, 71220
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4715
Country: JP	医薬品医療機器総合機構	Identifier(s): 2259702G2021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004213, 1084153
Country: MT	Medicines Authority	Identifier(s): MA211/01001, MA211/01002, PI1438/09101A, PI908/18601A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 161M82, 189M97
Country: NL	Z-Index G-Standaard	Identifier(s): 13804510, 13804529, 14691159
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 29378, 38717, 73377
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10628
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100008205, 100114137
Country: SG	Health Sciences Authority	Identifier(s): 02815P, 12002P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5213074
Country: US	FDA, National Drug Code	Identifier(s): 0597-0087, 50090-0961
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/10.2.1/0273, Z/10.2.1/48